Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radioembolization to Treat Primary and Metastatic Liver Tumors

NCT05240040 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05240040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radioembolization to Treat Primary and Metastatic Liver Tumors
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Withdrawn
Start date
April 26, 2016
Completion date
February 28, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic cholangiocarcinoma, liver tumor, metastatic cancer, metastatic liver cancer